No7 breaks record with Future Renew range

No7 has shattered records with the launch of its Future Renew collection, marking it as the brand’s fastest-selling product range to date. This groundbreaking super-peptide range, unveiled in April, achieved unprecedented success, surpassing the sales of any previous No7 launch within the first two weeks.

Charlotte Goodacre, No7 Beauty Advisor, expressed her astonishment at the overwhelming response from shoppers, describing it as “phenomenal” and “unlike anything we’ve seen before.” The launch saw eager customers queuing outside many No7 stores during the launch week, with products rapidly flying off the shelves. Customer feedback, whether online or in-store, has continued to be overwhelmingly positive. The Future Renew range features No7’s innovative super-peptide blend, representing a historic milestone in cosmetic science innovation for the brand. This blend taps into the skin’s natural repair process, stimulating the renewal of more than 50 crucial proteins in skin cells. Developed in collaboration with skin scientists from the University of Manchester, this super-peptide blend is the result of 15 years of dedicated research into skin aging and repair. It aims to be one of the most effective and well-tolerated skincare ingredients available in the cosmetic market. At the heart of the Future Renew collection lies the No7 Future Renew Damage Reversal Serum, designed to reverse the appearance of various visible signs of skin damage across a diverse range of skin types and tones. Complementary products include a Day Cream, Night Cream, and Eye Serum. Dr. Mike Bell, Head of Science Research at No7, emphasised the brand’s commitment to providing exceptional results and affordable luxury to customers, drawing on 88 years of innovation and scientific breakthroughs. No7 takes pride in offering products supported by clinical trials and peer-reviewed science to the high street, making high-quality skincare accessible to all.